Våtsveen TK, Giliberto M, Bjornsdottir V, Centonze F, Besse A, Frey Y, Skånland SS, Tveita A, Alirezaylavasani A, Imbery JF, Misund K, Reiterer V, Zahoor M, Driessen C, Besse L, Tasken K, Schjesvold FH, Farhan H, Munthe LA(2025) Targeting proteostasis in multiple myeloma through inhibition of LTK Leukemia(in press) DOI 10.1038/s41375-025-02682-8, PubMed 40634511
Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS(2025) Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia Clin Cancer Res, 31(10), 1943-1955 DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050
Wei Q, Foyn H, Landskron J, Wang S, Rye IH, Skånland SS, Russnes HEG, Klaveness J, Ahmad R, Taskén K(2025) Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3 iScience, 28(3), 111931 DOI 10.1016/j.isci.2025.111931, PubMed 40034859